Reiteration - Spark Newswire

2 minute read

How Ferrari’s EV Future Could Lead To $350 Per Share: Analyst

Today, 2:02 PM

Morgan Stanley analyst Adam Jonas released a note on Wednesday detailing how electric vehicles could drive Ferrari N.V. (NYSE: RACE) shares to $350. The Ferrari Analyst: Morgan Stanley maintained an Overweight rating on Ferrari with a $265 price target.

RACE

2 minute read

Why This Bed Bath & Beyond Analyst Is Raising Their Price Target By 60%

By Shanthi Rexaline

Today, 2:02 PM

Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported last week with strong quarterly revenues, although earnings missed expectations.

BBBY

1 minute read

Should Investors Buy Amazon Stock Following Its Streaming Deal With Comcast?

By Adam Eckert

Today, 2:02 PM

CNBC's "Squawk Box" host Melissa Lee reported Friday that Amazon.com Inc (NASDAQ: AMZN) signed a new streaming deal with Comcast Corp (NASDAQ: CMCSA).

AMZN

1 minute read

Costco Shares Gain Premarket After June Sales Jump 16.9%, Morgan Stanley Raises Price Target

By Shivani Kumaresan

Today, 2:02 PM

Costco Wholesale Corporation (NASDAQ:COST) reported net sales of $18.92 billion for the retail month of June, a 16.9% growth year-on-year. The…

COST

2 minute read

6 Top Precious Metal Stock Picks

By Wayne Duggan

Today, 2:02 PM

On Thursday, Bank of America updated its precious metal price outlook and named its top precious metal stock picks for investors to buy heading into the second half of 2021.

FNV

1 minute read

Why JPMorgan Is Raising Tesla Delivery Estimates, EPS Estimates, Price Target

By Nikhil Dayal

Today, 2:02 PM

JPMorgan analysts increased several estimates for Tesla, Inc. (NASDAQ: TSLA) Wednesday following the automaker’s second-quarter vehicle delivery update.

TSLA

1 minute read

Arrowhead’s Big Sell-Off Presents Buying Opportunity, According to HC Wainwright

By Nikhil Dayal

Today, 2:02 PM

The sell-off on shares of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) tied to the ARO-EnAC phase 1/2 study halt is overdone, leading H.C. Wainwright & Co. to reiterate its Buy rating.

ARWR

1 minute read

Takeaways On Unity Biotech’s Clinical Data From A Bull Analyst

By Nikhil Dayal

Today, 2:02 PM

Positive results from primary clinical data regarding UBX1325 have H.C. Wainwright & Co. analysts bullish UNITY Biotechnology, Inc. (NASDAQ: UBX). The Unity Biotech Analyst: Andrew Fein reaffirmed a Buy rating on shares of Unity Biotech with a $12 price target.

UBX

1 minute read

Bullish Arbutus Biopharma Analyst Breaks Down Pipeline Opportunity

By Nikhil Dayal

Today, 2:02 PM

The expected start of combination clinical trials has H.C. Wainwright bullish on shares of Arbutus Biopharma Corp. (NASDAQ: ABUS). The Arbutus Analyst: Ed Arce raffirmed a Buy rating on shares of Arbutus Biopharma Corp. with a $10 price target.

ABUS

1 minute read

Why This ChemoCentryx Analyst Is Bullish

By Nikhil Dayal

Today, 2:02 PM

H.C. Wainwright analysts remain bullish on ChemoCentryx, Inc. (NASDAQ: CCXI) following an amended new drug application for avacopan. The ChemoCentryx Analyst: Edward White reaffirmed a Buy rating on shares of ChemoCentryx, Inc. with a $28 price target.

CCXI